LeMaitre Vascular, Inc. P/E Ratio 2009–2025
LeMaitre Vascular, Inc. reported 32.03 of price-to-earnings ratio for fiscal 2025. That was 32.0% lower than fiscal 2024. Compared with fiscal 2020, the change was -13.4%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 32.03 | -32.0% |
| FY 2024 | 47.08 | +13.6% |
| FY 2023 | 41.44 | -13.5% |
| FY 2022 | 47.92 | +24.5% |
| FY 2021 | 38.50 | +4.1% |
| FY 2020 | 36.99 | -3.5% |
| FY 2019 | 38.31 | +97.4% |
| FY 2018 | 19.40 | -43.0% |
| FY 2017 | 34.06 | -19.1% |
| FY 2016 | 42.07 | +13.4% |
| FY 2015 | 37.11 | +25.3% |
| FY 2014 | 29.61 | -15.4% |
| FY 2013 | 35.01 | +13.6% |
| FY 2012 | 30.82 | -19.9% |
| FY 2011 | 38.46 | +152.0% |
| FY 2010 | 15.26 | -63.4% |
| FY 2009 | 41.71 | — |
Source: LeMaitre Vascular, Inc. SEC filings — fiscal-year-end price ÷ diluted EPS. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open LMAT 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
LeMaitre Vascular, Inc. reported 32.03 of price-to-earnings ratio for fiscal 2025. That was 32.0% lower than fiscal 2024. Compared with fiscal 2020, the change was -13.4%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for LeMaitre Vascular, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeLeMaitre Vascular, Inc. — frequently asked questions
What is LeMaitre Vascular, Inc.'s price-to-earnings ratio?
LeMaitre Vascular, Inc. (LMAT) reported price-to-earnings ratio of 32.03 for fiscal year 2025, per its SEC filings.
How has LeMaitre Vascular, Inc.'s price-to-earnings ratio changed over time?
Between fiscal 2009 and 2025, LMAT's price-to-earnings ratio declined at roughly 1.6% per year (compound annual rate), from 41.71 to 32.03.
Where does this data come from?
Figures are computed from LeMaitre Vascular, Inc.'s official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.
More LMAT financial history
Full LMAT fundamentals page → · Analyze price-to-earnings ratio with a free tool → · Research guide & leaders → · All 1,500+ companies →